. 2016 Jul 20;2016:7402760. doi: 10.1155/2016/7402760

Table 2.

LGG dose and time of exposure modulated the MFI of DC surface markers.

Marker	Group	Control	5 : 1	10 : 1	100 : 1
MHC class II	DC 2 h	1191 ± 10	2522 ± 2^a	2545 ± 94^a	2978 ± 245^a
	DC 18 h	1303 ± 37	2066 ± 154^a	2124 ± 29^a	1530 ± 3^bc
	DC + neutrophils	1191 ± 28	2010 ± 107^a	2352 ± 78^a	1946 ± 80^ac

CD40	DC 2 h	539 ± 1	629 ± 1^a	654 ± 1^a	684 ± 6^abc
	DC 18 h	489 ± 42	735 ± 27^a	721 ± 1^a	370 ± 8^bc
	DC + neutrophils	437 ± 61	576 ± 15	642 ± 18^a	390 ± 21^c

CD83	DC 2 h	465 ± 20	417 ± 11	554 ± 79	452 ± 22
	DC 18 h	668 ± 20	506 ± 33^a	681 ± 7^b	702 ± 12^b
	DC + neutrophils	704 ± 34	609 ± 61^a	441 ± 54^a	351 ± 3^ab

CD80	DC 2 h	515 ± 4	537 ± 5	516 ± 14	568 ± 15^ac
	DC 18 h	513 ± 3	544 ± 12	535 ± 10	478 ± 28^b
	DC + neutrophils	476 ± 6	613 ± 16^a	553 ± 10^a	478 ± 21^bc

^a p < 0.05 compared to control with no bacteria.

^{b, c} p < 0.05 compared to groups treated with 5 : 1 and 10 : 1 LGG, respectively.

Data are presented as the mean ± SEM.